Literature DB >> 9299618

A single sequence change destabilizes the influenza virus neuraminidase tetramer.

J M Colacino1, N Y Chirgadze, E Garman, K G Murti, R J Loncharich, A J Baxter, K A Staschke, W G Laver.   

Abstract

A single change (E119G) in the influenza A virus N9 neuraminidase (NA) results in resistance of the enzyme to the NA inhibitor 4-Guanidino-Neu5Ac2en (4-GuDANA). This change causes a salt link between Glu119, which sits in a pocket in the bottom of the active site of the enzyme, and the 4-guanidinium moiety of the inhibitor to be lost. NA "heads" of the resistant enzyme produced only a few small crystals under conditions in which the wild-type enzyme readily formed large crystals. These small crystals were of sufficient quality to yield X-ray crystallographic data which confirmed the E119G change and demonstrated the presence of electron density representing either a strong structural-water molecule or an anionic species in place of the glutamate carboxylate. NA heads of the resistant enzyme also have greatly reduced NA activity per milligram of total protein. We have now found that the mutant NA heads consist predominantly of monomers with a few dimers and tetramers, as determined by electron microscopic analysis of the protein. The low level of enzymatic activity as well as the small number of crystals obtained were probably from the few tetramers remaining intact in the preparation. The purified wild-type and 4-GuDANA-resistant enzymes were treated with the homobifunctional NHS-ester cross linker, DTSSP. SDS-PAGE analysis of the treated enzymes clearly revealed cross-linked dimers of the wild-type enzyme. In contrast, only a small proportion of the 4-GuDANA-resistant neuraminidase was cross-linked. An examination of the known X-ray crystallographic structure of the wild-type NA reveals a salt bridge between Glu119 and Arg156 of the same monomer. Arg156 is a conserved amino acid that is situated at the interface between monomers, and a salt link between this amino acid and Glu119 may contribute to the stability of enzyme tetramers. It is suggested that the E119G alteration in the 4-GuDANA-resistant NA leads to the abrogation of this interaction and thus to the instability of the NA tetramers. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299618     DOI: 10.1006/viro.1997.8709

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs.

Authors:  Nathalie Bastien; Jonathan B Gubbay; David Richardson; Katrina Sleeman; Larisa Gubareva; Yan Li
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

2.  Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.

Authors:  Andrés Pizzorno; Yacine Abed; Chantal Rhéaume; Xavier Bouhy; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 3.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 4.  Zanamivir: an update of its use in influenza.

Authors:  Susan M Cheer; Antona J Wagstaff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Zanamivir: a review of its use in influenza.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 6.  Antiviral adhesion molecular mechanisms for influenza: W. G. Laver's lifetime obsession.

Authors:  Elspeth F Garman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

7.  Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system.

Authors:  Jennifer Tisoncik-Go; Katie S Cordero; Lijun Rong
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

8.  Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.

Authors:  Natalia A Ilyushina; Jon P Seiler; Jerold E Rehg; Robert G Webster; Elena A Govorkova
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Authors:  C Y Tai; P A Escarpe; R W Sidwell; M A Williams; W Lew; H Wu; C U Kim; D B Mendel
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.

Authors:  Xueyong Zhu; Hannah L Turner; Shanshan Lang; Ryan McBride; Sandhya Bangaru; Iuliia M Gilchuk; Wenli Yu; James C Paulson; James E Crowe; Andrew B Ward; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2019-11-19       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.